Moderna
MRNA
#1139
Rank
HK$155.50 B
Marketcap
HK$392.10
Share price
-1.52%
Change (1 day)
77.74%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2025 : HK$96.69 Billion

According to Moderna 's latest financial reports the company's total assets are HK$96.69 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31HK$95.99 B-12.56%
2024-12-31HK$109.79 B-23.71%
2023-12-31HK$143.90 B-28.77%
2022-12-31HK$202.03 B5.03%
2021-12-31HK$192.35 B238.2%
2020-12-31HK$56.87 B359.49%
2019-12-31HK$12.37 B-19.44%
2018-12-31HK$15.36 B81.34%
2017-12-31HK$8.47 B-22.9%
2016-12-31HK$10.98 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
HK$1.561 T 1,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$869.54 B 799.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$1.072 T 1,009.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.58 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$58.21 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$38.92 B-59.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$12.57 B-87.00%๐Ÿ‡บ๐Ÿ‡ธ USA